oru.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Patch testing with own cosmetics: a prospective study of testing and reporting of adverse effects to the Swedish Medical Products Agency
Department of Cosmetics, Medical Products Agency, Uppsala, Sweden.
Örebro University, School of Health and Medical Sciences, Örebro University, Sweden. Department of Dermatology, Örebro University Hospital, Örebro, Sweden.
Department of Occupational and Environmental Dermatology, Skåne University, Malmö, Sweden.
Department of Dermatology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Show others and affiliations
2012 (English)In: Contact Dermatitis, ISSN 0105-1873, E-ISSN 1600-0536, Vol. 67, no 1, p. 42-46Article in journal (Refereed) Published
Abstract [en]

Background: The Swedish Medical Products Agency (MPA) provides a voluntary reporting system for adverse reactions to cosmetics. However, the reporting is sparse, and the products involved are sometimes difficult to identify.

Objectives: To investigate how often patients referred for patch testing were tested with the cosmetic products that they had been using themselves, and to improve the reporting to the MPA by the use of photographic documentation of product labels.

Patients and methods: Consecutive patients at five dermatology departments who were patch tested with their own cosmetics were included. Reports including protocols of positive patch test results for the patients' own cosmetics and photographs/photocopies of product labels were sent to the MPA. Results. Three hundred and sixteen of 948 patients (33%) were tested with their own cosmetics, and 15% of these tested positive with one or more products. The number of reports was more than three times higher than in corresponding periods in earlier years. For 79% of the products, photographs/photocopies of the containers were submitted, and for 30%, batch numbers were submitted.

Conclusions: For a substantial number of patients, their own cosmetics were suspected of causing adverse reactions and were therefore tested. During the study, the number of reports to the MPA tripled, and the relevant products were easier to identify.

Place, publisher, year, edition, pages
Hoboken, USA: Wiley-Blackwell, 2012. Vol. 67, no 1, p. 42-46
Keywords [en]
Adverse cosmetic reactions, cosmetovigilance, patch testing, reporting system
National Category
Medical and Health Sciences Dermatology and Venereal Diseases
Research subject
Medicine
Identifiers
URN: urn:nbn:se:oru:diva-24630DOI: 10.1111/j.1600-0536.2012.02058.xISI: 000304993100007PubMedID: 22443095Scopus ID: 2-s2.0-84862167273OAI: oai:DiVA.org:oru-24630DiVA, id: diva2:545777
Available from: 2012-08-21 Created: 2012-08-21 Last updated: 2018-08-29Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records BETA

Lindberg, Magnus

Search in DiVA

By author/editor
Lindberg, Magnus
By organisation
School of Health and Medical Sciences, Örebro University, Sweden
In the same journal
Contact Dermatitis
Medical and Health SciencesDermatology and Venereal Diseases

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 22 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf